Assertion: untreated chronic lymphocytic leukemia | /r/HasProperty | small lymphocytic lymphoma
Facets:
Source sentences:
text: The U.S. Food and Drug Administration (FDA) approved approved the use of ibrutinib (IMBRUVICA) in combination with obinutuzumab (GAZYVA) for the treatment of adult patients with previously untreated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).